ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc (HEMO)

1.37
0.05
(3.79%)
Closed July 26 11:30AM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 00000000
Operating Income -459k-740k-1.59M-1.46M-2.13M-2.66M-5.53M-5.21M
Pre Tax Income -471k-2.41M-1.59M-1.49M-2.1M-5.11M-3.99M-6.7M
Net Income -471k-2.36M-1.54M-1.45M-2.08M-5.1M-3.98M-6.69M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.7-0.7-0.4-0.4-0.5-0.5-0.4-0.6
EBIT -459k-2.37M-1.59M-1.46M-2.13M-2.66M-5.53M-5.21M
EBITDA -447k-706k-1.53M-1.36M-2.03M-2.53M-4.97M-4.56M